Firms begin study on chewable albendazole formulation

Fidson Health Care Plc has partnered with a clinical research organisation, Liddie BE Ltd to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets.

Musa Adekunle

Latest news today on Fidelis Ayebae

Firms begin study on chewable albendazole formulation

Shareholders okay NEM’s N1.5 billion total dividend

NEM Insurance posts 23% increase in net premium in 2021

‘Fidson is committed to providing affordable, high quality pharmaceuticals to Nigerians’

Reasons most African countries won’t get COVID-19 vaccines until April

Stakeholders raise alarm as local drug manufacturing nears collapse

Delayed bailout unsettles aviation, health sectors

Experts explain rise in prices of pharmaceuticals, others

NEM offers investors N687 million dividend

Underwriter offers shareholders N687 million dividend

Furore over rise in fake drugs-induced deaths, treatment failures worldwide

GSK, Fidson partner on contract manufacturing, technology transfer

Fidson posts N16.23 billion turnover, seeks fresh capital

Yakasai inaugurates Safe Medicines Foundation, unveils advocacy book

NEM Insurance records N10.9b premium

NDC Slams Delta Assembly Over Vacant Seat Declaration, Alleges Political Persecution

NBA rejects alleged AGF directives, insists 2026 national officers' poll will hold

Ogun Lawyers protest, halts court proceedings over unfavorable work policies

EFCC transfers over 1,440 recovered assets to education ministry

The News You Need, Delivered To You.